Remove 2002 Remove Biosimilars Remove Insurance Coverage and Processing
article thumbnail

Top Performing Drug – Enbrel (June Edition)

PharmaShots

In July 2002, Amgen acquired the rights to Enbrel as part of its acquisition of Immunex. Some of the alternative drugs for Enbrel include: Enbrel’s Biosimilars6 As Enbrel has a long journey in the market it is already facing competition from biosimilars in the US and other countries. and Canada. Enbrel Prescribing Information 3.